Title: Is hip disarticulation for bone and soft tissue sarcomas still justified in modern era of treatment?

Authors: Vikas Warikoo, Nikhil Garg, Abhijeet Ashok Salunke

 DOI: https://dx.doi.org/10.18535/jmscr/v7i9.128

Abstract

  

Background: Hip disarticulation is the radical amputation of the lower limb through the hip joint. Hip disarticulation is a treatment modality tumours with neurovascular encasement and non-responsive to chemotherapy.

Patients & Methods: The study included 38 retrospective cases of patients who were operated in our institute with hip disarticulation for bone and soft tissue sarcoma from 2013 to 2018. Patients were analysed by tumour type, extent of disease and intent of surgical intervention (curative, curative/palliative, palliative). Disease free survival (DFS) and post-operative overall survival (OS) were calculated from the time of surgery to the last follow-up or date of death.

Results: The median DFS for all patients was 12 months, the median OS was 17 months and one year survival rate was 63.88%. When this manuscript was drafted, only 42% of the patients in the sample were alive.

Conclusion: Hip disarticulation is a major surgical procedure and proper planning is required. Hip disarticulation will continue to feature in the sarcoma surgeon’s armamentarium for unresectable tumours.

Keywords: Hip disarticulation, bone sarcoma, soft tissue sarcoma, survival rate.

Editorial Policy

Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not ..

Read More.....

Frequency of Publication

JMSCR is published as monthly journal with 12 issues per year. Special editions are also planned subjected to the scope and need....

Read more...

Submission of Articles

Authors are invited to submit their research articles, review papers, Case Report properly formatted as per the author guidelines.........

Read more...